Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ermenegildo Zegna (ZGN) Liabilities and Shareholders Equity (2020 - 2025)

Ermenegildo Zegna (ZGN) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $3.3 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 8.96% to $3.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.8 billion through Dec 2025, up 4.32% year-over-year, with the annual reading at $3.3 billion for FY2025, 8.96% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $3.3 billion at Ermenegildo Zegna, up from $3.0 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $3.3 billion in Q4 2025, with the low at $2.5 billion in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $2.9 billion, with a median of $3.0 billion recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity dropped 11.94% in 2022, then increased 20.25% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $2.8 billion in 2021, then fell by 11.94% to $2.5 billion in 2022, then rose by 20.25% to $3.0 billion in 2023, then grew by 1.72% to $3.0 billion in 2024, then rose by 8.96% to $3.3 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $3.3 billion, $3.0 billion, and $3.0 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.